TELEFLEX INC
TFXNYSE
$134.61
↓ -0.5%Jul 17 close · end-of-day
Price
1Y↑ +20.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$6.0B
Enterprise Value
$8.3B
P/E
—
P/S
2.8
P/B
1.9
EV/EBITDA
32.3
PEG
—
FCF Yield
—
Dividend Yield
1.0%
Revenue (TTM)
$2.1B
Net Income (TTM)
-$1.0B
Free Cash Flow (TTM)
—
Gross Margin
55.1%
Operating Margin
2.9%
Net Margin
-47.4%
ROE
-32.7%
ROIC
0.9%
Debt / Equity
0.8
Net Cash
-$2.3B
Return 1Y
+19.9%
Company profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems. The company also offers interventional products, which consists of various coronary, structural heart therapies, and peripheral intervention and cardiac assist products.
- CEO
- Liam J. Kelly
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 15,500
- Headquarters
- Pennsylvania
- Website
- teleflex.com
Earnings
TFX Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$548.3M↑ +32.3%
Diluted EPS-$0.18↓ -108.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.8B | $2.8B | $1.7B | $1.7B | $2.0B |
| Gross profit | $1.3B | $1.5B | $1.5B | $1.0B | $1.0B | $1.1B |
| Operating income | $423.1M | $628.1M | $499.7M | $258.7M | $103.7M | $118.4M |
| Net income | $335.3M | $485.4M | $363.1M | $357.6M | $70.2M | -$905.6M |
| Diluted EPS | $7.09 | $10.23 | $7.68 | $7.53 | $1.48 | -$20.25 |
| Operating cash flow | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | 52.2% | 55.2% | 54.9% | 60.7% | 61.0% | 56.2% |
| Operating margin | 16.7% | 22.4% | 17.9% | 15.1% | 6.1% | 5.9% |
| Net margin | 13.2% | 17.3% | 13.0% | 20.9% | 4.1% | -45.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $418.5M | $426.2M | $442.0M | $414.3M | $442.5M | $566.9M | $569.0M | $548.3M |
| Gross profit | $251.7M | $260.3M | $268.8M | $255.4M | $265.8M | $292.0M | $307.4M | $307.4M |
| Operating income | $51.1M | $72.0M | $52.4M | $75.8M | $91.1M | -$62.4M | $13.9M | $20.2M |
| Net income | $80.0M | $111.0M | -$136.7M | $95.0M | $122.6M | -$408.9M | -$714.3M | -$8.2M |
| Diluted EPS | $1.69 | $2.36 | -$2.93 | $2.07 | $2.77 | -$9.24 | -$16.15 | -$0.18 |
| Operating cash flow | — | — | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 60.1% | 61.1% | 60.8% | 61.7% | 60.1% | 51.5% | 54.0% | 56.1% |
| Operating margin | 12.2% | 16.9% | 11.9% | 18.3% | 20.6% | -11.0% | 2.4% | 3.7% |
| Net margin | 19.1% | 26.0% | -30.9% | 22.9% | 27.7% | -72.1% | -125.5% | -1.5% |
Company news
Jun 24, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.